Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment
| Image |  |
|---|---|
| Description | scientific article published on 27 January 2017 |
| Author/s |
author: Mark Sulkowski Fred Poordad |
| Publication date | January 27, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |